Media Coverage

Bioanalytical Needs And Biosimilars: How Does The Molecule Compare?

Once the patent on a previously ground-breaking blockbuster molecule comes to an end, there is an opportunity for biosimilar versions of this product to enter the market. Often presenting a more cost-effective alternative, biosimilars can provide greater access to critical therapeutics.

Click for full article

abstract chromosome illustration